BioCentury
ARTICLE | Distillery Therapeutics

Endocrine / metabolic disease

December 13, 2017 1:12 AM UTC

In vitro and mouse studies suggest inhibiting SEPP1 could help treat diabetes. Screening of a mAb library via in vitro and mouse myoblast cell-based SEPP1 binding assays identified a mAb that bound th...